Literature DB >> 8373445

Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse.

P V Nerurkar1, S S Park, P E Thomas, R W Nims, R A Lubet.   

Abstract

The cytochrome P450 isozyme specificity for the O-dealkylation of methoxyresorufin (MTR) and benzyloxyresorufin (BZR) in the rat and mouse was investigated. The induction of various alkoxyresorufin O-dealkylation activities was measured in male F344/NCr rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3,4,5,3',4',5'-hexachlorobiphenyl. MTR and ethoxyresorufin (ETR) O-dealkylation activities were induced 30- and 80-fold, respectively, in the liver. ETR O-dealkylation activity was induced > 250-fold in the kidney, whereas the metabolism of MTR was induced only 30-fold in this extrahepatic tissue. Phenacetin, a fairly specific CYP1A2 inhibitor, caused concentration-dependent competitive inhibition of MTR O-dealkylation (ki approximately 20 microM at 0.5 microM substrate) in hepatic microsomes from 3,4,5,3',4',5'-hexachlorobiphenyl-treated rats. The corresponding ki for inhibition of ETR O-dealkylation by phenacetin was > or = 333 microM at a 0.5 microM substrate concentration. A monoclonal antibody displaying inhibitory activity against rat CYP1A1 inhibited ETR O-dealkylation activity, whereas it failed to inhibit MTR O-dealkylation activity. In contrast, a monoclonal antibody reactive with both CYP1A1 and CYP1A2 inhibited both O-dealkylation activities to an equal extent. Similar experiments, employing phenacetin or specific monoclonal antibodies, yielded comparable results when performed with mouse microsomes. The maximal induction of MTR O-dealkylation activity in mice was > 100-fold. The P450 isozyme specificity of BZR O-dealkylation was also examined in both rats and mice. Pregnenolone-alpha-carbonitrile, a strong inducer of CYP3A, only weakly induced BZR O-dealkylation activity. In addition, a monoclonal antibody that specifically inhibits CYP2B caused inhibition of BZR metabolism in microsomes from phenobarbital- or dexamethasone-pretreated rats. In B6C3F1 mice exposed to dietary Aroclor 1254, significant induction of hepatic MTR O-dealkylation activity was observed at concentrations lower than those required for the induction of ETR or BZR O-dealkylation. In summary, it would appear that MTR is a relatively specific substrate for CYP1A2 activity in rodents, while BZR appears to be relatively specific for CYP2B.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373445     DOI: 10.1016/0006-2952(93)90504-p

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

1.  Significant increase in phenacetin oxidation on L382V substitution in human cytochrome P450 1A2.

Authors:  Qingbiao Huang; Grazyna D Szklarz
Journal:  Drug Metab Dispos       Date:  2010-03-24       Impact factor: 3.922

2.  Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5.

Authors:  Robert D Finn; Lesley A McLaughlin; Sebastien Ronseaux; Ian Rosewell; J Brian Houston; Colin J Henderson; C Roland Wolf
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

3.  Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice.

Authors:  P R Sinclair; N Gorman; T Dalton; H S Walton; W J Bement; J F Sinclair; A G Smith; D W Nebert
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

4.  Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.

Authors:  Qingbiao Huang; Rahul S Deshmukh; Spencer S Ericksen; Youbin Tu; Grazyna D Szklarz
Journal:  Drug Metab Dispos       Date:  2012-09-04       Impact factor: 3.922

5.  Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-/-) mice.

Authors:  Eugene Hrycay; Dana Forrest; Lin Liu; Renxue Wang; Jenny Tai; Anand Deo; Victor Ling; Stelvio Bandiera
Journal:  Mol Cell Biochem       Date:  2014-01-08       Impact factor: 3.396

6.  Environmentally persistent free radicals inhibit cytochrome P450 activity in rat liver microsomes.

Authors:  James R Reed; George F Cawley; Taylor G Ardoin; Barry Dellinger; Slawomir M Lomnicki; Farhana Hasan; Lucy W Kiruri; Wayne L Backes
Journal:  Toxicol Appl Pharmacol       Date:  2014-04-05       Impact factor: 4.219

7.  Apiaceous vegetable consumption decreases PhIP-induced DNA adducts and increases methylated PhIP metabolites in the urine metabolome in rats.

Authors:  Jae Kyeom Kim; Daniel D Gallaher; Chi Chen; Dan Yao; Sabrina P Trudo
Journal:  J Nutr       Date:  2014-12-24       Impact factor: 4.798

8.  Preferential inhibition of CYP1A enzymes in hepatic microsomes by mexiletine.

Authors:  H Konishi; K Morita; T Minouchi; A Yamaji
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.441

9.  Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants.

Authors:  Youbin Tu; Rahul Deshmukh; Meena Sivaneri; Grazyna D Szklarz
Journal:  Drug Metab Dispos       Date:  2008-08-14       Impact factor: 3.922

10.  3,3',4,4',5-Pentachlorobiphenyl (PCB 126) Decreases Hepatic and Systemic Ratios of Epoxide to Diol Metabolites of Unsaturated Fatty Acids in Male Rats.

Authors:  Xianai Wu; Jun Yang; Christophe Morisseau; Larry W Robertson; Bruce Hammock; Hans-Joachim Lehmler
Journal:  Toxicol Sci       Date:  2016-05-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.